Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
How to Trip Rapid Review
Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)
Step 2: press
Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.
The use of newer progestins for contraception. The synthetic progestins used for contraception so far are structurally related either to testosterone (estranes and gonanes) or to progesterone (pregnanes and 19-norpregnanes). Several new progestins have been designed to minimize side-effects related to androgenic, estrogenic or glucocorticoid receptor (GR) interactions. Dienogest (DNG) and drospirenone (DRSP) exhibit a partial antiandrogenic action, and DRSP has predominant anti (...) -mineralocorticoid properties. The 19-norpregnanes include Nestorone (NES), nomegestrol acetate (NOMAc) and trimegestone (TMG), and possess a high specificity for binding to the progesterone receptor (PR) with no or little interaction with other steroid receptors. DRSP has been developed as combination oral pills with ethinyl estradiol (EE); DNG has been combined both with EE and, more recently, with estradiol valerate (E2V). NOMAc has been used as a progestin-only method and more recently combined
of starting most hormonal contraception (implant, injection, combined hormonal contraceptives, and progestin-only pills) likely exceed any risk, and a pregnancy test should be repeated in 2–4 weeks. If there is uncertainty about a luteal phase pregnancy, an LNG-IUD should not be inserted until the clinician is reasonably certain that the patient is not pregnant. The copper IUD may be inserted within 5 days of unprotected intercourse for emergency contracep- tion (19). Additional information about “quick (...) . Darney P, Patel A, Rosen K, Shapiro LS, Kaunitz AM. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril 2009;91:1646–53. ^ 58. Vickery Z, Madden T, Zhao Q, Secura GM, Allsworth JE, Peipert JF. Weight change at 12 months in users of three progestin-only contraceptive methods. Contraception 2013;88:503–8. ^ 59. Bonny AE, Ziegler J, Harvey R, Debanne SM, Secic M, Cromer BA. Weight gain in obese and nonobese adolescent girls
pregnancy loss was initially reported in the early 1990s,shortlyaftervaginalultrasonographybecamewidely available. Based on these early studies, a crown–rump length (CRL) of 5 mm without cardiac activity or an empty gestational sac measuring 16 mm in mean gestational sac diameter have been used as diagnostic criteria to confirm early pregnancy loss (10, 11). Recently, two large pro- spective studies have been used to challenge these cutoffs. In the first study, 1,060 women with intrauterine pregnan (...) pregnancy loss, the use of progestins is controversial, and conclusive evidence supporting their use is lacking (65). Women who have experi- enced at least three prior pregnancy losses, however, may benefit from progesterone therapy in the first tri- mester (7). Summary of Recommendations and Conclusions The following recommendation and conclusion are based on good and consistent scientific evidence (Level A): < In patients for whom medical management of early pregnancy loss is indicated, initial
. Womenwithsymptomaticuterineleiomyomasexperienceheavyuterinebleeding,bulksymptoms,miscarriages, and pregnancy complications. Surgical therapies such as myomectomy or hysterectomy are highly effective; however, medical therapy with progestin-predominant contraceptives or gonadotropin-releasing hormone (GnRH) agonists are in many ways inadequate to address the unmet need for better, noninvasive, and cost-effective treatments. Recent advances in medical treatment, such as selective progesterone receptor modulators, new oral GnRH analogs (...) leiomyomas include uncontrollable fac- tors such as increasing age, early menarche, late menopause, black ethnicity, and genetics. Lifestyle factors include obe- sity, dietary habits, and reduced physical activity, as well as early use of oral contraceptives (OCs). Increased parity and injectable progestins reduce the incidence. 4 Thediagnosisofuterineleiomyomasismadeafteracareful and thorough history and physical examination. Unusual complaints may include pain from ureteric obstruction, acute pain
estrogen-free contraceptives. All progestins exert activity through binding to specific progesterone receptors; hereby, three different groups of progestins exist: pregnanes, gonanes, and estranges. Progestins also comprise specific glucocorticoid, androgen, or mineralocorticoid receptor interactions. Anabolic action of a progestogen may be affected via androgenic, anti-androgenic, or synadrogenic activity. The C 19 nortestosterone class of progestogens is known to bind with more affinity to androgen (...) receptors than the C21 progestins. This article reviews the effect of estrogens and progestogens on bone and presents new data of the currently approved drospirenone-only pill. The use of progestin-only contraceptives leading to an estradiol level between 30 and 50 pg/ml does not seem to lead to an accelerate bone loss.
, and in vitro fertilization 2.12.1 Methods of contraception Contraceptive methods include combined hormonal contracep- tives (oestrogen/progestin), progestogen-only methods, intrauter- ine devices, and emergency contraception. Their use needs to be balanced against the risk of pregnancy. In 2010, the Centers for Disease Control (CDC) modi?ed the WHO suggestions for medical eligibility criteria for contraceptive use in women with CVD. [http://www.cdc.gov/Mmwr/preview/ mmwrhtml/rr59e0528a13.htm]. Monthly (...) on the underlying heart disease as well as on additional factors such as ventricular and valvular function, functional class, and cyanosis. The miscar- riage rate is higher in more complex disease (Figure 1). 56 Maternal cardiac complications are present in 12% of completed pregnan- cies and are again more frequent as the disease becomes more complex. Patients who experience complications during pregnancy may also be at higher risk of late cardiac events after pregnancy. 74 Offspring complications, including
Differential Regulation of Intestinal Efflux Transporters by Pregnancy in Mice 1. In the intestines, the nuclear receptors farnesoid X receptor (Fxr) and pregnane X receptor (Pxr) regulate the transcription of metabolizing enzymes and transporters that dictate the absorption of nutrients and xenobiotics. 2. Here, we sought to determine whether Fxr and Pxr signaling pathways are disrupted in response to high-circulating concentrations of steroid hormones late in pregnancy leading to altered (...) , transporter mRNA expression was quantified in human intestinal LS174T adenocarcinoma cells. In vitro data demonstrated that progestins reduced CYP3A4, MDR1 and MRP2 mRNA expression by 30-40%. 4. These data suggest that progesterone may act as a mediator to negatively regulate efflux transporter expression in the mouse ileum during pregnancy possibly by reducing PXR/Pxr signaling. This may affect drug absorption and disposition during pregnancy.
heparin, low molecular weight heparin or fondaparinux should be administered. 2.3.2 OTHER MEDICAL PATIENTS a Patients with cancer are generally at high risk of venous thromboembolism and should be considered for prophylaxis with low molecular weight heparin, unfractionated heparin or fondaparinux whilst hospitalised. 2.4 Pregnan Cy and the Puer Perium 2.4.1 ANTENATAL THROMBOSIS RISK ASSESSMENT d all women should be assessed for risk factors for venous thromboembolism when booking for antenatal care
metabolites, as responsible for this protection. However, the progesterone metabolite, allopregnanolone (3α-hydroxy-5α-pregnan-20-one), also prevents lordosis inhibition after restraint. In a prior study, we reported that the progestin receptor antagonist, RU486 (11β-(4-dimethylamino)phenyl-17β-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one), attenuated the effect of allopregnanolone. Because RU486 can also block the glucocorticoid receptor, in the current studies, we evaluated the effect of the progestin
Ultrasound-guided hysteroscopy to remove a levonorgestrel intrauterine system in early pregnancy. Correctly placed levonorgestrel-releasing intrauterine systems (LNG-IUSs) are rarely associated with intrauterine pregnancy when pregnancy occurs. LNG-IUS retrieval, termination of pregnancy and conservative management if retracted strings prevent ready removal are the usual clinical options given to women. The conservative course raises concerns about teratogenesis related to high local progestin (...) exposure for the developing fetus.This case report describes combined saline hysteroscopy and ultrasound to retrieve an LNG-IUS at less than 9 weeks of gestational age. A systematic review of the literature was performed to identify similar case reports by contacting the manufacturer and searching Pubmed from 1900 through November 2011 using the terms ((levonorgestrel AND intrauterine) OR mirena) AND (pregnan* OR fetal OR fetus OR teratogen*) NOT (menorrhagia OR hyperplas* OR ectopic OR malig
and Nestorone strongly increased the reappearance of cells of the oligodendroglial lineage in the demyelinated slices. In contrast to Nestorone, the pregnane derivative medroxyprogesterone acetate had no effect. The increase in oligodendroglial cells by Nestorone resulted from enhanced NG2(+) and Olig2(+) oligodendrocyte progenitor cell (OPC) recruitment. In cocultures of lysolecithin-demyelinated cerebellar slices from wild-type mice apposed to brain stem slices of proteolipid gene promoter-EGFP mice (...) , Nestorone stimulated the migration of OPC towards demyelinated axons. In this coculture paradigm, Nestorone indeed markedly increased the number of EGFP(+) cells migrating into the demyelinated cerebellar slices. Our results show that Nestorone stimulates the recruitment and maturation of OPC, two steps which are limiting for efficient myelin repair. They may thus open new perspectives for the use of progestins, which selectively target PR, to promote the endogenous regeneration of myelin.
Progesterone â€žReceptorsâ€ in the Cytoplasm and Nucleus of Chick Oviduct Target Tissue This report demonstrates that the chick oviduct, a specific target organ for progesterone, contains both cytoplasmic and nuclear macromolecules which bind progestins. These binding molecules can be clearly distinguished from transcortin by centrifugation through sucrose gradients of low ionic strength and by agarose gel filtration. The cytoplasmic progesterone-binding molecules also bind 5-alpha-pregnane